Product Information
LEVETIRACETAM 500 MG TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.0739 per EA under NDC 16571078850. Its NADAC has been published 244 times since Dec 22, 2021.
FDA first approved this application on Jan 15, 2009. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500 mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
16571078850
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
LEVETIRACETAMApproval Type
Generic (ANDA)
FDA Application
ANDA078993FDA Approved
1/15/2009
TE Code
AB
On Market Since
1/15/2009
Pharmacological Classes
Price Statistics
The NADAC for LEVETIRACETAM 500 MG TABLET has been published 244 times since Dec 22, 2021, and over the history we have for it it has declined 24.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0739 per EA |
|---|---|
| All-time high | $0.1064 (Mar 16, 2022) |
| All-time low | $0.0608 (Nov 20, 2024) |
| 52-week high | $0.0799 |
| 52-week low | $0.0739 |
| Median price | $0.0842 |
| Average price | $0.0860 |
| Largest weekly change | -26.6% (Nov 20, 2024) |
| Weeks tracked | 244 |
| Tracking since | Dec 22, 2021 |
Generic Alternatives
The matcher finds 21 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 3% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of LEVETIRACETAM 500 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for LEVETIRACETAM 500 MG TABLET, manufactured by Rising Pharma Holdings Inc., is $0.0739 per EA (NDC 16571078850), effective Aug 19, 2026.
How has the price of LEVETIRACETAM 500 MG TABLET changed over time?
Over the history we have for it, the NADAC for LEVETIRACETAM 500 MG TABLET has declined 24.7%. It has been tracked across 244 weekly CMS publications since Dec 22, 2021.
What are the highest and lowest recorded NADAC prices for LEVETIRACETAM 500 MG TABLET?
Since Dec 22, 2021, the NADAC for LEVETIRACETAM 500 MG TABLET has ranged from a low of $0.0608 (Nov 20, 2024) to a high of $0.1064 (Mar 16, 2022), with a median of $0.0842 per EA.
Are there cheaper alternatives to LEVETIRACETAM 500 MG TABLET?
Yes. 21 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, LEVETIRACETAM 500 MG TABLET, is $0.0720 per EA — about 3% below LEVETIRACETAM 500 MG TABLET.
Who manufactures LEVETIRACETAM 500 MG TABLET?
LEVETIRACETAM 500 MG TABLET (NDC 16571078850) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.